Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1

Journal of Molecular Biology

Volumn 425, Issue 22, 2013, Pages 4405-4414

  Parker, Matthew W ^a   Linkugel, Andrew D ^a   Vander Kooi, Craig W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

angiogenesis; furin; peptide library; proteolysis; VEGF

Indexed keywords

AMINO ACID; ARGININE; FURIN; MEMBRANE PROTEIN; NEUROPILIN 1; SEMAPHORIN; SYNTHETIC PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CHO CELL; ESCHERICHIA COLI; ISOTHERMAL TITRATION CALORIMETRY; KALLMANN SYNDROME; LIGAND BINDING; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE LIBRARY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; WESTERN BLOTTING;

EID: 84886725991     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.07.017     Document Type: Article

References (50)

1. M.W. Parker, H.F. Guo, X. Li, A.D. Linkugel, and C.W. Vander Kooi Function of members of the neuropilin family as essential pleiotropic cell surface receptors Biochemistry 51 2012 9437 9446
2. L.M. Ellis The role of neuropilins in cancer Mol Cancer Ther 5 2006 1099 1107
3. P. Carmeliet VEGF as a key mediator of angiogenesis in cancer Oncology 69 2005 4 10
4. J.Z. Cui, B.J. Hinz, M.D. Greve, M.J. Potter, D. Hornan, and A. Samad Expression of neuropilin-1 in choroidal neovascular membranes Can J Ophthalmol 38 2003 41 45
5. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, and C.Y. Chung Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
6. B. Beck, G. Driessens, S. Goossens, K.K. Youssef, A. Kuchnio, and A. Caauwe A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours Nature 478 2011 399 403
7. H.L. Goel, B. Pursell, C. Chang, L.M. Shaw, J. Mao, and K. Simin GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation EMBO Mol Med 5 2013 488 508
8. S.P. Niclou, E.M. Ehlert, and J. Verhaagen Chemorepellent axon guidance molecules in spinal cord injury J Neurotrauma 23 2006 409 421
9. P.K. Hota, and M. Buck Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions Cell Mol Life Sci 69 2012 3765 3805
10. A. Starzec, R. Vassy, A. Martin, M. Lecouvey, M. Di Benedetto, and M. Crepin Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 Life Sci 79 2006 2370 2381
11. M.A. von Wronski, N. Raju, R. Pillai, N.J. Bogdan, E.R. Marinelli, and P. Nanjappan Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor J Biol Chem 281 2006 5702 5710
12. M.W. Parker, L.M. Hellman, P. Xu, M.G. Fried, and C.W. Vander Kooi Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin Biochemistry 49 2010 4068 4075
13. A. Jarvis, C.K. Allerston, H. Jia, B. Herzog, A. Garza-Garcia, and N. Winfield Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction J Med Chem 53 2010 2215 2226
14. M.L. Gagnon, D.R. Bielenberg, Z. Gechtman, H.Q. Miao, S. Takashima, and S. Soker Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity Proc Natl Acad Sci USA 97 2000 2573 2578
15. Q. Pan, Y. Chanthery, W.C. Liang, S. Stawicki, J. Mak, and N. Rathore Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth Cancer Cell 11 2007 53 67
16. W.C. Liang, M.S. Dennis, S. Stawicki, Y. Chanthery, Q. Pan, and Y. Chen Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library J Mol Biol 366 2007 815 829
17. B.A. Appleton, P. Wu, J. Maloney, J. Yin, W.C. Liang, and S. Stawicki Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding EMBO J 26 2007 4902 4912
18. G.Y. Perret, A. Starzec, N. Hauet, J. Vergote, M. Le Pecheur, and R. Vassy In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 Nucl Med Biol 31 2004 575 581
19. H. Benachour, A. Seve, T. Bastogne, C. Frochot, R. Vanderesse, and J. Jasniewski Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI Theranostics 2 2012 889 904
20. T. Teesalu, K.N. Sugahara, V.R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc Natl Acad Sci USA 106 2009 16157 16162
21. L. Roth, L. Agemy, V.R. Kotamraju, G. Braun, T. Teesalu, and K.N. Sugahara Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 31 2012 3754 3763
22. H. Jia, A. Bagherzadeh, B. Hartzoulakis, A. Jarvis, M. Lohr, and S. Shaikh Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling J Biol Chem 281 2006 13493 13502
23. C.W. Vander Kooi, M.A. Jusino, B. Perman, D.B. Neau, H.D. Bellamy, and D.J. Leahy Structural basis for ligand and heparin binding to neuropilin B domains Proc Natl Acad Sci USA 104 2007 6152 6157
24. M.W. Parker, P. Xu, X. Li, and C.W. Vander Kooi Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1 J Biol Chem 287 2012 11082 11089
25. R. Delcombel, L. Janssen, R. Vassy, M. Gammons, O. Haddad, and B. Richard New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation Angiogenesis 16 2013 353 371
26. S.J. Harper, and D.O. Bates VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8 2008 880 887
27. B. Olofsson, K. Pajusola, G. von Euler, D. Chilov, K. Alitalo, and U. Eriksson Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform J Biol Chem 271 1996 19310 19317
28. T. Karpanen, C.A. Heckman, S. Keskitalo, M. Jeltsch, H. Ollila, and G. Neufeld Functional interaction of VEGF-C and VEGF-D with neuropilin receptors FASEB J 20 2006 1462 1472
29. R.H. Adams, M. Lohrum, A. Klostermann, H. Betz, and A.W. Puschel The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing EMBO J 16 1997 6077 6086
30. C. Christensen, N. Ambartsumian, G. Gilestro, B. Thomsen, P. Comoglio, and L. Tamagnone Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis Cancer Res 65 2005 6167 6177
31. A. Varshavsky, O. Kessler, S. Abramovitch, B. Kigel, S. Zaffryar, and G. Akiri Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases Cancer Res 68 2008 6922 6931
32. H.Q. Miao, S. Soker, L. Feiner, J.L. Alonso, J.A. Raper, and M. Klagsbrun Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165 J Cell Biol 146 1999 233 242
33. C. Gu, B.J. Limberg, G.B. Whitaker, B. Perman, D.J. Leahy, and J.S. Rosenbaum Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165 J Biol Chem 277 2002 18069 18076
34. G. Serini, F. Bussolino, F. Maione, and E. Giraudo Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy J Intern Med 273 2013 138 155
35. R.J. Bender, and F. Mac Gabhann Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer PLoS One 8 2013 e61788
36. M. Hosaka, M. Nagahama, W.S. Kim, T. Watanabe, K. Hatsuzawa, and J. Ikemizu Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway J Biol Chem 266 1991 12127 12130
37. A. Starzec, P. Ladam, R. Vassy, S. Badache, N. Bouchemal, and A. Navaza Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex Peptides 28 2007 2397 2402
38. B. Herzog, C. Pellet-Many, G. Britton, B. Hartzoulakis, and I.C. Zachary VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation Mol Biol Cell 22 2011 2766 2776
39. N. Haspel, D. Zanuy, R. Nussinov, T. Teesalu, E. Ruoslahti, and C. Aleman Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach Biochemistry 50 2011 1755 1762
40. G.D. Fasman Prediction of protein structure and the principles of protein conformation 1989 Plenum Press New York
41. D. Zanuy, R. Kotla, R. Nussinov, T. Teesalu, K.N. Sugahara, and C. Aleman Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor J Struct Biol 182 2013 78 86
42. V.M. Gordon, K.R. Klimpel, N. Arora, M.A. Henderson, and S.H. Leppla Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases Infect Immun 63 1995 82 87
43. T. Watanabe, K. Murakami, and K. Nakayama Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway FEBS Lett 320 1993 215 218
44. S.S. Molloy, P.A. Bresnahan, S.H. Leppla, K.R. Klimpel, and G. Thomas Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen J Biol Chem 267 1992 16396 16402
45. B.J. Janssen, T. Malinauskas, G.A. Weir, M.Z. Cader, C. Siebold, and E.Y. Jones Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex Nat Struct Mol Biol 19 2012 1293 1299
46. M.W. Parker, P. Xu, H.F. Guo, and C.W. Vander Kooi Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition PLoS One 7 2012 e49177
47. N.K. Hanchate, P. Giacobini, P. Lhuillier, J. Parkash, C. Espy, and C. Fouveaut SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome PLoS Genet 8 2012 e1002896
48. B.A. Jardin, Y. Zhao, M. Selvaraj, J. Montes, R. Tran, and S. Prakash Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system J Biotechnol 135 2008 272 280
49. A.R. Aricescu, W. Lu, and E.Y. Jones A time- and cost-efficient system for high-level protein production in mammalian cells Acta Crystallogr Sect D Biol Crystallogr 62 2006 1243 1250
50. D.J. Leahy, C.E. Dann, P. Longo, B. Perman, and K.X. Ramyar A mammalian expression vector for expression and purification of secreted proteins for structural studies Protein Expression Purif 20 2000 500 506